Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2002
10/31/2002WO2000062766A3 Uses of ppar-gamma agonists in neutrophil-induced diseases
10/31/2002US20020161262 Use treating various medical conditions, including pain
10/31/2002US20020161237 (Z)-2-((2-bromo-4-(((3-hydroxybenzyl)amino)carbonyl)benzoyl) -amino)pent-2-enoic acid, for example; useful for treating psoriasis
10/31/2002US20020161054 And treatment of Chronic Obstructive Pulmonary Disease and allergic rhinitis
10/31/2002US20020161038 Inosine 5'-monophosphate dehydrogenase (IMPDH); prodrug having functional group -CO-N(-R)-COO-, a carrier, and an immunosuppressant, anticancer agent, antiviral agent, or anti-vascular hyperproliferation agent
10/31/2002US20020161033 Substituted 1,5-dihydropyrrol-2-one derivatives active as NMDA receptor antagonists for treatment of states of pain
10/31/2002US20020161025 N-substituted indole-3glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action
10/31/2002US20020161014 Purinyl substituted quinazoline-4-one derivatives
10/31/2002US20020161010 Treatment of various disorders associated with enhanced activity of kinase p38-alpha and/or transforming growth factor beta; antiinflammatory agents
10/31/2002US20020161006 1,4-dihydropyridine compounds as bradykinin antagonists
10/31/2002US20020160997 Novel indole derivatives
10/31/2002US20020160987 Novel 4-dedimethylaminotetracycline derivatives
10/31/2002US20020160982 Modafinil compound and cyclodextrin mixtures
10/31/2002US20020160948 Such as preventing or treating primary cancer cell growth
10/31/2002US20020160940 Modulation of endogenous gene expression in cells
10/31/2002US20020160478 Short peptides which selectively modulate the activity of protein kinases
10/31/2002US20020160438 Modulate kinase; antiinflammatory agents; respiratory system disorders
10/31/2002US20020160388 Compositions and methods relating to lung specific genes and proteins
10/31/2002US20020160015 Chemokine receptor able to bind to MCP-1, MIP-1 alpha and/or rantes and its uses
10/31/2002US20020158255 Compounds of the general formula P1-L-P2; wherein "P1" is a pyrazinoylguanidine sodium channel blocker, "L" is a linking group, and "P2" is either (i) a pyrazinoylguanidine sodium channel blocker or (ii) a P2Y2 receptor agonist, are disclosed
10/31/2002CA2483507A1 Enzyme and snp marker for disease
10/31/2002CA2445888A1 Chiral, broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions
10/31/2002CA2445740A1 Use of metals to treat inflammatory skin conditions
10/31/2002CA2445734A1 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue
10/31/2002CA2445729A1 Use of metals to treat mucosal membranes
10/31/2002CA2445236A1 Piperazino-derivatives and their use as pde4 inhibitor
10/31/2002CA2445233A1 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002CA2445188A1 Arylindenopyridines with pde inhibiting activity
10/31/2002CA2445168A1 Human timp-1 antibodies
10/31/2002CA2444675A1 Secreted proteins
10/31/2002CA2444599A1 Melanocortin receptor ligands
10/31/2002CA2444563A1 Tissue fibrosis inhibitors
10/31/2002CA2444235A1 New polynucleotides and polypeptides of the ifn.alpha.-17 gene
10/31/2002CA2443600A1 Heterocyclyldicarbamides as caspase inhibitors
10/31/2002CA2443587A1 Therapeutic treatments using the direct application of antimicrobial metal compositions
10/31/2002CA2443373A1 New polynucleotides and polypeptides of the erythropoietin gene
10/30/2002EP1252889A1 Remedies or preventives for pulmonary insufficiency containing diaminotrifluoromethylpyridine derivatives
10/30/2002EP1252333A2 Methods and materials relating to cd84-like polypeptides and polynucleotides
10/30/2002EP1252177A1 Ligand for vascular endothelial growth factor receptor
10/30/2002EP1252164A1 Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizine-5-yl acetic acid
10/30/2002EP1252163A2 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
10/30/2002EP1252158A1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes
10/30/2002EP1252157A1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
10/30/2002EP1252154A1 Heterocyclic amide derivatives
10/30/2002EP1252153A1 Substituted piperidines, medicaments containing these compounds, and methods for the production thereof
10/30/2002EP1252152A1 Urea compounds as inhibitors for vla-4
10/30/2002EP1252144A1 Substituted glutarimides and use thereof il-12 production inhibitors
10/30/2002EP1252133A2 Pharmaceutical compounds
10/30/2002EP1251868A1 Combination therapy for the treatment of inflammatory and respiratory diseases
10/30/2002EP1251852A1 Use of desloratadine for treating allergic and inflammatory conditions
10/30/2002EP1251851A1 Treating allergic and inflammatory conditions
10/30/2002EP1251848A1 Gyrase inhibitors and uses thereof
10/30/2002EP1251829A1 Electrospun pharmaceutical compositions
10/30/2002EP1251739A2 Poly(dipeptide) as a drug carrier
10/30/2002EP1051425B1 2-(PURIN-9-yl)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVES
10/30/2002EP0812195B1 Pharmaceutical composition for piperidinoalkanol compounds
10/30/2002CN1377356A Certain alkylene diamine-substituted heterocycles
10/30/2002CN1377355A Amino substituted pyrazolo [1,5-2]-1,5-pyrimidines and pyrazolo [1,5-2]-1,3, 5-triazines
10/30/2002CN1377353A Purine derivatives having phosphodiesterase IN inhibition activity
10/30/2002CN1377352A Selective antagonists of A28 adenosine receptors
10/30/2002CN1377347A 药学活性磺酰胺衍生物 Pharmaceutically active sulfonamide derivatives
10/30/2002CN1377346A Z-pyrazoline-5-ones
10/30/2002CN1377271A Use of thienopyrimidines
10/30/2002CN1377268A Cell adhesion inhibitors
10/30/2002CN1377262A Method and composition for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses
10/30/2002CN1377259A ACE-2 inhibiting compounds and methods of use thereof
10/30/2002CN1376512A Throat-mistening notoginseng medicine
10/30/2002CN1376504A Intravenous injection of Chinese angelica root and its preparing process
10/30/2002CN1376494A Chinese medicine for treating silicosis
10/30/2002CN1376490A Preparing process and prescription of loquat syrup for treating cough
10/30/2002CN1376484A Medicine 'Sanqi Houshuang' for relieving throat disease
10/30/2002CN1376482A Medicine 'Sanqihua Houshuang' for relieving throat disease
10/30/2002CN1093415C Chinese medicine for curing cough and asthma
10/30/2002CN1093413C Traditional Chinese medicine for treating asthma
10/30/2002CA2383469A1 Treatment of t-cell mediated diseases
10/29/2002US6472562 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
10/29/2002US6472530 Benzo-fused dithiepino[6,5-b]pyridines, and related compositions and methods
10/29/2002US6472418 Non-peptide NK1 receptors antagonists
10/29/2002US6472412 Compounds as PDE IV and TNF inhibitors
10/29/2002US6472390 Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
10/29/2002US6472386 Cyclic diamine compound with 5-membered ring groups
10/29/2002US6472165 Modulatory binding site in potassium channels for screening and finding new active ingredients
10/25/2002EP1194142A4 Salts of cis -4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl) cyclohexan-1-carboxylate!
10/24/2002WO2002084249A2 Therapeutic and diagnostic uses of antibody specificity profiles
10/24/2002WO2002083873A2 Enzymes
10/24/2002WO2002083870A2 Pufa polyketide synthase systems and uses thereof
10/24/2002WO2002083736A2 G-protein coupled receptor molecules and uses thereof
10/24/2002WO2002083712A2 Transporters and ion channels
10/24/2002WO2002083709A2 Kinases and phosphatases
10/24/2002WO2002083700A2 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
10/24/2002WO2002083693A1 Thiazolopyrimidines and their use as modulators of chemokine receptor activity
10/24/2002WO2002083673A1 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders
10/24/2002WO2002083668A1 Isoxaxole derivatives as inhibitors of src and other protein kinases
10/24/2002WO2002083667A2 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/24/2002WO2002083664A1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
10/24/2002WO2002083663A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
10/24/2002WO2002083645A1 Novel compounds
10/24/2002WO2002083642A1 Compounds useful as anti-inflammatory agents
10/24/2002WO2002083628A1 1,4-disubstituted benzo-fused compounds
10/24/2002WO2002083627A2 Ligands des integrins avss6
1 ... 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 ... 878